Back to today’s briefing

Story perspectives

FDA Lifts Warning on Menopause Hormone Therapy After 20 Years

11/22/2025

50 5 Full Breakdown

Summary

Story summary

The U.S. Food and Drug Administration (FDA) has removed the black box warning on menopause hormone replacement therapy.
This decision, after more than 20 years, follows research showing the risks were overstated.
Experts say hormone replacement therapy (HRT) can alleviate menopause symptoms and may reduce heart disease risk if started within 10 years of menopause.
Women under 60 are ideal candidates.
Individual health evaluations remain crucial.

1 of 1

Story summary

The U.S. Food and Drug Administration (FDA) has removed the black box warning on menopause hormone replacement therapy.
This decision, after more than 20 years, follows research showing the risks were overstated.
Experts say hormone replacement therapy (HRT) can alleviate menopause symptoms and may reduce heart disease risk if started within 10 years of menopause.
Women under 60 are ideal candidates.
Individual health evaluations remain crucial.